Asia · General news · The Japan News (Yomiuri)
Japan OK’s insurance coverage of Alzheimer’s drug lecanemab
Detailed summary
An advisory panel to the health minister on Friday approved public health insurance coverage for an injection version of lecanemab, an Alzheimer’s medicine developed by Eisai Co.…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (japannews.yomiuri.co.jp)
